durapatite has been researched along with rhenium in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodack, JW; Chinen, LK; Chinol, M; Deutsch, EA; Deutsch, KF; Goldsmith, SJ; Klein, MJ; Tofe, AJ; Vallabhajosula, S; Watson, BA | 1 |
Glatz, S; Grillenberger, KG; Reske, SN | 1 |
El-Mabhouh, AA; Mercer, JR | 1 |
Berry, D; Blower, PJ; Bordoloi, JK; de Rosales, RT; Khan, IU; Shanahan, C; Sunassee, K | 1 |
Beekman, FJ; Bloemendal, HJ; de Klerk, JMH; Hendrikse, NH; Lange, R; Ramakers, RM; Ter Heine, R; van der Westerlaken, MML | 1 |
Belchior, A; Correia, JD; Fernandes, C; Gano, L; Marques, F; Monteiro, S; Santos, I | 1 |
Makris, G; Papadopoulos, MS; Papagiannopoulou, D; Pirmettis, I; Tseligka, ED; Vizirianakis, IS | 1 |
7 other study(ies) available for durapatite and rhenium
Article | Year |
---|---|
Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy.
Topics: Animals; Arthritis, Experimental; Durapatite; Hydroxyapatites; Injections, Intra-Articular; Rabbits; Radioisotopes; Rhenium; Samarium; Synovial Membrane | 1993 |
Rhenium-188 labeled hydroxyapatite and rhenium-188 sulfur colloid. In vitro comparison of two agents for radiation synovectomy.
Topics: Arthritis, Rheumatoid; Drug Stability; Durapatite; Humans; Isotope Labeling; Kinetics; Radioisotopes; Rhenium; Sulfur; Synovial Fluid; Synovial Membrane | 1997 |
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.
Topics: Animals; Bone and Bones; Bone Neoplasms; Cattle; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Durapatite; Etidronic Acid; Female; Gemcitabine; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2008 |
Technetium-99m and rhenium-188 complexes with one and two pendant bisphosphonate groups for imaging arterial calcification.
Topics: Animals; Blood Proteins; Calcinosis; Diphosphonates; Durapatite; Female; Humans; Hydrazines; Ligands; Male; Mesenteric Arteries; Organotechnetium Compounds; Radioisotopes; Rats; Rhenium; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2015 |
Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical 188Rhenium-HEDP.
Topics: Animals; Bone and Bones; Durapatite; Etidronic Acid; Male; Mice; Mice, Inbred C57BL; Radiochemistry; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2015 |
Novel (188)Re multi-functional bone-seeking compounds: Synthesis, biological and radiotoxic effects in metastatic breast cancer cells.
Topics: Animals; Biological Transport; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Durapatite; Female; Mice; Neoplasm Metastasis; Organometallic Compounds; Radioisotopes; Rhenium; Tissue Distribution | 2016 |
Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.
Topics: Bone and Bones; Cell Line, Tumor; Chelating Agents; Chromatography, High Pressure Liquid; Diphosphonates; Durapatite; Humans; Ligands; MCF-7 Cells; Organotechnetium Compounds; Radiopharmaceuticals; Rhenium; Technetium; Tissue Distribution | 2016 |